The Pro Medicus share price is down 42% from its euphoric 2025 peak. Is the nosediving sentiment justified, or overdone?

Defence spending shows delivery discipline, negotiations with EU near closure amid strategic urgency, large-cap results set ...

Planning to buy a MacBook Pro? Apple’s online store is showing extended delivery timelines for several high-end ...

Clients with revenue above $20 million continue to grow consistently faster than the company average. In this Moneycontrol ...

Google has rolled out a new “Answer Now” option in the Gemini app, allowing users to skip the AI’s in-depth reasoning phase ...

Consumer Durables, Realty, Pharmaceutical, and Healthcare stocks each declined approximately 2 percent, with the Auto index ...

The Marks and Spencer share price lost all of its momentum in 2025 after a cyberattack crippled online sales. Now, however, it's back in business. The post Prediction: analysts reckon the Marks and ...

Microsoft’s January 2026 security update for Windows 11 has introduced an odd and frustrating bug for a small subset of users ...

A new leak claims Samsung Display has already begun mass production of advanced OLED panels said to be destined for Apple’s ...

What is the connection between Donald Trump’s eyeing Greenland and seeking regime change in Iran with India’s Union Budget, ...

Profound Medical PROF shares soared 9.5% in the last trading session to close at $8.34. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...

The policy corridor is buzzing with the Budget preparations. But elsewhere too, action is building up. The corporate earnings report cards, high-frequency PMIs and US jobs, among others, are catching ...